{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T23:38:35Z","timestamp":1726184315747},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T00:00:00Z","timestamp":1503964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Different subtypes of bone marrow-derived stem cells are characterized by varying functionality and activity after transplantation into the infarcted heart. Improvement of stem cell therapeutics requires deep knowledge about the mechanisms that mediate the benefits of stem cell treatment. Here, we demonstrated that co-transplantation of mesenchymal stem cells (MSCs) and hematopoietic stem cells (HSCs) led to enhanced synergistic effects on cardiac remodeling. While HSCs were associated with blood vessel formation, MSCs were found to possess transdifferentiation capacity. This cardiomyogenic plasticity of MSCs was strongly promoted by a gap junction-dependent crosstalk between myocytes and stem cells. The inhibition of cell-cell coupling significantly reduced the expression of the cardiac specific transcription factors NKX2.5 and GATA4. Interestingly, we observed that small non-coding RNAs are exchanged between MSCs and cardiomyocytes in a GJ-dependent manner that might contribute to the transdifferentiation process of MSCs within a cardiac environment. Our results suggest that the predominant mechanism of HSCs contribution to cardiac regeneration is based on their ability to regulate angiogenesis. In contrast, transplanted MSCs have the capability for intercellular communication with surrounding cardiomyocytes, which triggers the intrinsic program of cardiogenic lineage specification of MSCs by providing cardiomyocyte-derived cues.<\/jats:p>","DOI":"10.1038\/s41598-017-10122-6","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T08:57:58Z","timestamp":1503478678000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mechanisms of stem cell based cardiac repair-gap junctional signaling promotes the cardiac lineage specification of mesenchymal stem cells"],"prefix":"10.1038","volume":"7","author":[{"given":"Heiko","family":"Lemcke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Gaebel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Skorska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Voronina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia Aquilina","family":"Lux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Petters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Sasse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Zarniko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustav","family":"Steinhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"David","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,29]]},"reference":[{"key":"10122_CR1","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1093\/eurheartj\/ehr018","volume":"32","author":"J Tongers","year":"2011","unstructured":"Tongers, J., Losordo, D. W. & Landmesser, U. Stem and progenitor cell-based therapy in ischaemic heart disease: Promise, uncertainties, and challenges. European Heart Journal \n                           32, 1197\u20131206 (2011).","journal-title":"European Heart Journal"},{"key":"10122_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1053\/j.semtcvs.2014.03.001","volume":"26","author":"NC Ni","year":"2014","unstructured":"Ni, N. C. et al. The promise and challenges of cardiac stem cell therapy. Semin. Thorac. Cardiovasc. Surg. \n                           26, 44\u201352 (2014).","journal-title":"Semin. Thorac. Cardiovasc. Surg."},{"key":"10122_CR3","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1001\/jama.2012.64751","volume":"308","author":"E Marban","year":"2012","unstructured":"Marban, E. & Malliaras, K. Mixed results for bone marrow \u2013 derived cell therapy for ischemic heart disease. J. Am. Med. Assoc. \n                           308, 2405\u20132406 (2012).","journal-title":"J. Am. Med. Assoc."},{"key":"10122_CR4","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.109.901405","volume":"121","author":"E Chavakis","year":"2010","unstructured":"Chavakis, E., Koyanagi, M. & Dimmeler, S. Enhancing the outcome of cell therapy for cardiac repair: Progress from bench to bedside and back. Circulation \n                           121, 325\u2013335 (2010).","journal-title":"Circulation"},{"key":"10122_CR5","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.105.590653","volume":"114","author":"AJ Boyle","year":"2006","unstructured":"Boyle, A. J., Schulman, S. P. & Hare, J. M. Stem cell therapy for cardiac repair: Ready for the next step. Circulation \n                           114, 339\u2013352 (2006).","journal-title":"Circulation"},{"key":"10122_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.atherosclerosis.2012.03.017","volume":"223","author":"A Blum","year":"2012","unstructured":"Blum, A., Balkan, W. & Hare, J. M. Advances in cell-based therapy for peripheral vascular disease. Atherosclerosis \n                           223, 269\u2013277 (2012).","journal-title":"Atherosclerosis"},{"issue":"Suppl 1","key":"10122_CR7","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1038\/ncpcardio0429","volume":"3","author":"A Behfar","year":"2006","unstructured":"Behfar, A. & Terzic, A. Derivation of a cardiopoietic population from human mesenchymal stem cells yields cardiac progeny. Nat. Clin. Pract. Cardiovasc. Med. \n                           3(Suppl 1), S78\u2013S82 (2006).","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"10122_CR8","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00277-005-1068-7","volume":"84","author":"J Yoon","year":"2005","unstructured":"Yoon, J., Shim, W. J., Ro, Y. M. & Lim, D.-S. Transdifferentiation of mesenchymal stem cells into cardiomyocytes by direct cell-to-cell contact with neonatal cardiomyocyte but not adult cardiomyocytes. Ann. Hematol. \n                           84, 715\u201321 (2005).","journal-title":"Ann. Hematol."},{"key":"10122_CR9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.bbrc.2004.09.087","volume":"324","author":"WSN Shim","year":"2004","unstructured":"Shim, W. S. N. et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem. Biophys. Res. Commun. \n                           324, 481\u2013488 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10122_CR10","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.jacc.2010.03.066","volume":"56","author":"A Behfar","year":"2010","unstructured":"Behfar, A. et al. Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction. J. Am. Coll. Cardiol. \n                           56, 721\u2013734 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10122_CR11","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1161\/hc0102.101442","volume":"105","author":"C Toma","year":"2002","unstructured":"Toma, C. Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart. Circulation \n                           105, 93\u201398 (2002).","journal-title":"Circulation"},{"key":"10122_CR12","doi-asserted-by":"crossref","unstructured":"Shen, H. et al. Mesenchymal Stem Cells for Cardiac Regenerative Therapy: Optimization of Cell Differentiation Strategy. Stem Cells Int. 2015 (2015).","DOI":"10.1155\/2015\/524756"},{"key":"10122_CR13","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1634\/stemcells.2008-0329","volume":"26","author":"RA Rose","year":"2008","unstructured":"Rose, R. A. et al. Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in vitro. Stem Cells \n                           26, 2884\u20132892 (2008).","journal-title":"Stem Cells"},{"key":"10122_CR14","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1089\/scd.2011.0626","volume":"21","author":"G Siegel","year":"2012","unstructured":"Siegel, G. et al. Bone marrow-derived human mesenchymal stem cells express cardiomyogenic proteins but do not exhibit functional cardiomyogenic differentiation potential. Stem Cells Dev. \n                           21, 2457\u20132470 (2012).","journal-title":"Stem Cells Dev."},{"key":"10122_CR15","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/stem.1086","volume":"30","author":"AA Ramkisoensing","year":"2012","unstructured":"Ramkisoensing, A. A. et al. Gap junctional coupling with cardiomyocytes is necessary but not sufficient for cardiomyogenic differentiation of cocultured human mesenchymal stem cells. Stem Cells \n                           30, 1236\u201345 (2012).","journal-title":"Stem Cells"},{"key":"10122_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1161\/CIRCULATIONAHA.110.982918","volume":"123","author":"T Hosoda","year":"2011","unstructured":"Hosoda, T. et al. Human cardiac stem cell differentiation is regulated by a mircrine mechanism. Circulation \n                           123, 1287\u20131296 (2011).","journal-title":"Circulation"},{"key":"10122_CR17","doi-asserted-by":"publisher","first-page":"2658","DOI":"10.1161\/01.CIR.0000145609.20435.36","volume":"110","author":"M Xu","year":"2004","unstructured":"Xu, M. et al. Differentiation of bone marrow stromal cells into the cardiac phenotype requires intercellular communication with myocytes. Circulation \n                           110, 2658\u20132665 (2004).","journal-title":"Circulation"},{"key":"10122_CR18","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1002\/jcp.24982","volume":"230","author":"S Zhang","year":"2015","unstructured":"Zhang, S. et al. Gap junctions enhance the antiproliferative effect of microRNA-124-3p in glioblastoma cells. J. Cell. Physiol. Physiol. \n                           230, 2476\u20132488 (2015).","journal-title":"J. Cell. Physiol. Physiol."},{"key":"10122_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.bbamem.2004.09.009","volume":"1711","author":"DW Laird","year":"2005","unstructured":"Laird, D. W. Connexin phosphorylation as a regulatory event linked to gap junction internalization and degradation. Biochim. Biophys. Acta \n                           1711, 172\u201382 (2005).","journal-title":"Biochim. Biophys. Acta"},{"key":"10122_CR20","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbamem.2003.11.022","volume":"1662","author":"GS Goldberg","year":"2004","unstructured":"Goldberg, G. S., Valiunas, V. & Brink, P. R. Selective permeability of gap junction channels. Biochim. Biophys. Acta \n                           1662, 96\u2013101 (2004).","journal-title":"Biochim. Biophys. Acta"},{"key":"10122_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2013.00204","volume":"4","author":"T Hosoda","year":"2013","unstructured":"Hosoda, T. The mircrine mechanism controlling cardiac stem cell fate. Front. Genet. \n                           4, 204 (2013).","journal-title":"Front. Genet."},{"key":"10122_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/182645","volume":"2014","author":"M Laupheimer","year":"2014","unstructured":"Laupheimer, M. et al. Selective Migration of Subpopulations of Bone Marrow Cells along an SDF-1 \u03b1 and ATP Gradient. Bone Marrow Res. \n                           2014, 1\u201310 (2014).","journal-title":"Bone Marrow Res."},{"key":"10122_CR23","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/S0301-472X(02)00812-3","volume":"30","author":"N Quirici","year":"2002","unstructured":"Quirici, N. et al. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp. Hematol. \n                           30, 783\u2013791 (2002).","journal-title":"Exp. Hematol."},{"key":"10122_CR24","doi-asserted-by":"publisher","first-page":"431","DOI":"10.3109\/14653249.2011.651533","volume":"14","author":"R Cuthbert","year":"2012","unstructured":"Cuthbert, R. et al. Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use. Cytotherapy \n                           14, 431\u2013440 (2012).","journal-title":"Cytotherapy"},{"key":"10122_CR25","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1111\/j.1582-4934.2012.01617.x","volume":"16","author":"M Crisan","year":"2012","unstructured":"Crisan, M., Corselli, M., Chen, W. C. W. & P\u00e9ault, B. Perivascular cells for regenerative medicine. J. Cell. Mol. Med. \n                           16, 2851\u20132860 (2012).","journal-title":"J. Cell. Mol. Med."},{"key":"10122_CR26","doi-asserted-by":"publisher","first-page":"513","DOI":"10.3727\/096368914X678436","volume":"23","author":"SH Chou","year":"2014","unstructured":"Chou, S. H. et al. Mesenchymal stem cell insights: Prospects in cardiovascular therapy. Cell Transplantation \n                           23, 513\u2013529 (2014).","journal-title":"Cell Transplantation"},{"key":"10122_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1113\/jphysiol.2005.090985","volume":"568","author":"V Valiunas","year":"2005","unstructured":"Valiunas, V. et al. Connexin-specific cell-to-cell transfer of short interfering RNA by gap junctions. J. Physiol. \n                           568, 459\u2013468 (2005).","journal-title":"J. Physiol."},{"key":"10122_CR28","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jtcvs.2010.12.013","volume":"142","author":"P Donndorf","year":"2011","unstructured":"Donndorf, P. et al. Intramyocardial bone marrow stem cell transplantation during coronary artery bypass surgery: a meta-analysis. J. Thorac. Cardiovasc. Surg. \n                           142, 911\u201320 (2011).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10122_CR29","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2459\/JCM.0b013e328343d708","volume":"12","author":"A Colombo","year":"2011","unstructured":"Colombo, A. et al. Myocardial blood flow and infarct size after CD133 cell injection in large myocardial infarction with good recanalization and poor reperfusion: Results from a randomized controlled trial. J. Cardiovasc. Med. \n                           12, 239\u2013248 (2011).","journal-title":"J. Cardiovasc. Med."},{"key":"10122_CR30","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.jtcvs.2011.05.002","volume":"142","author":"C Yerebakan","year":"2011","unstructured":"Yerebakan, C. et al. Impact of preoperative left ventricular function and time from infarction on the long-term benefits after intramyocardial CD133(+) bone marrow stem cell transplant. J. Thorac. Cardiovasc. Surg. \n                           142, 1530\u20131539.e3 (2011).","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10122_CR31","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3727\/096368912X657431","volume":"22","author":"S Carrancio","year":"2012","unstructured":"Carrancio, S. et al. Effects of MSC-co-administration and route of delivery on cord blood hematopoietic stem cell engraftment. Cell Transplant. \n                           22, 1171\u20131183 (2012).","journal-title":"Cell Transplant."},{"key":"10122_CR32","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3324\/haematol.2009.015065","volume":"95","author":"S Ku\u00e7i","year":"2010","unstructured":"Ku\u00e7i, S. et al. CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties. Haematologica \n                           95, 651\u2013659 (2010).","journal-title":"Haematologica"},{"key":"10122_CR33","doi-asserted-by":"crossref","unstructured":"Lin, Y. & Hogan, W. J. Clinical application of mesenchymal stem cells in the treatment and prevention of graft-versus-host disease. Adv. Hematol. 2011 (2011).","DOI":"10.1155\/2011\/427863"},{"key":"10122_CR34","doi-asserted-by":"publisher","first-page":"14022","DOI":"10.1073\/pnas.0903201106","volume":"106","author":"HC Quevedo","year":"2009","unstructured":"Quevedo, H. C. et al. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc. Natl. Acad. Sci. USA \n                           106, 14022\u20137 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10122_CR35","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0003-4975(02)03517-8","volume":"73","author":"JG Shake","year":"2002","unstructured":"Shake, J. G. et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann. Thorac. Surg. \n                           73, 1919\u20131926 (2002).","journal-title":"Ann. Thorac. Surg."},{"key":"10122_CR36","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s11373-007-9188-9","volume":"14","author":"SM Nassiri","year":"2007","unstructured":"Nassiri, S. M. et al. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. J. Biomed. Sci. \n                           14, 745\u2013755 (2007).","journal-title":"J. Biomed. Sci."},{"key":"10122_CR37","doi-asserted-by":"publisher","unstructured":"Amsalem, Y. et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation, doi:10.1161\/CIRCULATIONAHA.106.680231 (2007).","DOI":"10.1161\/CIRCULATIONAHA.106.680231"},{"key":"10122_CR38","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3109\/14653240902988818","volume":"11","author":"R Koninckx","year":"2009","unstructured":"Koninckx, R. et al. Human bone marrow stem cells co-cultured with neonatal rat cardiomyocytes display limited cardiomyogenic plasticity. Cytotherapy \n                           11, 778\u2013792 (2009).","journal-title":"Cytotherapy"},{"key":"10122_CR39","doi-asserted-by":"crossref","unstructured":"Ramkisoensing, A. A. et al. Human embryonic and fetal Mesenchymal stem cells differentiate toward three different cardiac lineages in contrast to their adult counterparts. PLoS One \n                           6 (2011).","DOI":"10.1371\/journal.pone.0024164"},{"key":"10122_CR40","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","volume":"103","author":"M Gnecchi","year":"2008","unstructured":"Gnecchi, M., Zhang, Z., Ni, A. & Dzau, V. J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. \n                           103, 1204\u20131219 (2008).","journal-title":"Circ. Res."},{"key":"10122_CR41","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.vph.2012.04.002","volume":"57","author":"M Gnecchi","year":"2012","unstructured":"Gnecchi, M., Danieli, P. & Cervio, E. Mesenchymal stem cell therapy for heart disease. Vascul. Pharmacol. \n                           57, 48\u201355 (2012).","journal-title":"Vascul. Pharmacol."},{"key":"10122_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-016-0341-0","volume":"7","author":"A Singh","year":"2016","unstructured":"Singh, A., Singh, A. & Sen, D. Mesenchymal stem cells in cardiac regeneration: a detailed progress report of the last 6 years (2010\u20132015). Stem Cell Res. Ther. \n                           7, 82 (2016).","journal-title":"Stem Cell Res. Ther."},{"key":"10122_CR43","first-page":"63","volume":"11","author":"R Hosseinikia","year":"2017","unstructured":"Hosseinikia, R. et al. Molecular and Cellular Interactions of Allogenic and Autologus Mesenchymal Stem Cells with Innate and Acquired Immunity and Their Role in Regenerative Medicine. International Journal of Hematology-Oncology and Stem Cell Research \n                           11, 63\u201377 (2017).","journal-title":"International Journal of Hematology-Oncology and Stem Cell Research"},{"key":"10122_CR44","doi-asserted-by":"publisher","first-page":"15566","DOI":"10.18632\/oncotarget.3904","volume":"6","author":"X Hong","year":"2015","unstructured":"Hong, X., Sin, W. C., Harris, A. L. & Naus, C. C. Gap junctions modulate glioma invasion by direct transfer of microRNA. Oncotarget \n                           6, 15566\u201315577 (2015).","journal-title":"Oncotarget"},{"key":"10122_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-11-29","volume":"11","author":"A Cseleny\u00e1k","year":"2010","unstructured":"Cseleny\u00e1k, A., Pankotai, E., Horv\u00e1th, E. M., Kiss, L. & Lacza, Z. Mesenchymal stem cells rescue cardiomyoblasts from cell death in an in vitro ischemia model via direct cell-to-cell connections. BMC Cell Biol. \n                           11, 29 (2010).","journal-title":"BMC Cell Biol."},{"key":"10122_CR46","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1111\/j.1582-4934.2007.00205.x","volume":"12","author":"EY Plotnikov","year":"2008","unstructured":"Plotnikov, E. Y. et al. Cell-to-cell cross-talk between mesenchymal stem cells and cardiomyocytes in co-culture. J. Cell. Mol. Med. \n                           12, 1622\u201331 (2008).","journal-title":"J. Cell. Mol. Med."},{"key":"10122_CR47","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.cellsig.2015.09.012","volume":"27","author":"H Lemcke","year":"2015","unstructured":"Lemcke, H., Steinhoff, G. & David, R. Gap junctional shuttling of miRNA - A novel pathway of intercellular gene regulation and its prospects in clinical application. Cell. Signal. \n                           27, 2506\u20132514 (2015).","journal-title":"Cell. Signal."},{"key":"10122_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0129999","volume":"10","author":"S Liu","year":"2015","unstructured":"Liu, S., Niger, C., Koh, E. Y. & Stains, J. P. Connexin43 Mediated Delivery of ADAMTS5 Targeting siRNAs from Mesenchymal Stem Cells to Synovial Fibroblasts. PLoS One \n                           10, e0129999 (2015).","journal-title":"PLoS One"},{"key":"10122_CR49","doi-asserted-by":"publisher","first-page":"346","DOI":"10.18632\/oncotarget.868","volume":"4","author":"HKH Lee","year":"2013","unstructured":"Lee, H. K. H. et al. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget \n                           4, 346\u2013361 (2013).","journal-title":"Oncotarget"},{"key":"10122_CR50","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1158\/0008-5472.CAN-10-2372","volume":"71","author":"PK Lim","year":"2011","unstructured":"Lim, P. K. et al. Gap junction-mediated import of microRNA from bone marrow stromal cells can elicit cell cycle quiescence in breast cancer cells. Cancer Res. \n                           71, 1550\u20131560 (2011).","journal-title":"Cancer Res."},{"key":"10122_CR51","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.bbrc.2012.03.092","volume":"420","author":"Llu Zhang","year":"2012","unstructured":"Zhang, Llu. et al. MiR-499 induces cardiac differentiation of rat mesenchymal stem cells through wnt\/\u03b2-catenin signaling pathway. Biochem. Biophys. Res. Commun. \n                           420, 875\u201381 (2012).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10122_CR52","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.biomaterials.2012.09.069","volume":"34","author":"SY Lee","year":"2013","unstructured":"Lee, S. Y. et al. The promotion of cardiogenic differentiation of hMSCs by targeting epidermal growth factor receptor using microRNA-133a. Biomaterials \n                           34, 92\u201399 (2013).","journal-title":"Biomaterials"},{"key":"10122_CR53","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.yexcr.2016.02.005","volume":"341","author":"MJ Cha","year":"2016","unstructured":"Cha, M. J. et al. The microRNA-dependent cell fate of multipotent stromal cells differentiating to endothelial cells. Exp. Cell Res. \n                           341, 139\u2013146 (2016).","journal-title":"Exp. Cell Res."},{"key":"10122_CR54","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ejphar.2015.10.030","volume":"768","author":"P Michela","year":"2015","unstructured":"Michela, P., Velia, V., Aldo, P. & Ada, P. Role of connexin 43 in cardiovascular diseases. Eur. J. Pharmacol. \n                           768, 71\u201376 (2015).","journal-title":"Eur. J. Pharmacol."},{"key":"10122_CR55","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1073\/pnas.0700416104","volume":"104","author":"BJ Muller-Borer","year":"2007","unstructured":"Muller-Borer, B. J. et al. Mechanisms controlling the acquisition of a cardiac phenotype by liver stem cells. Proc. Natl. Acad. Sci. USA. \n                           104, 3877\u201382 (2007).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10122_CR56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1097\/FJC.0000000000000183","volume":"65","author":"D Dakhlallah","year":"2015","unstructured":"Dakhlallah, D. et al. MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart. J. Cardiovasc. Pharmacol. \n                           65, 241\u201351 (2015).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10122_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ijcard.2015.03.425","volume":"188","author":"C Liu","year":"2015","unstructured":"Liu, C. et al. Pretreatment of mesenchymal stem cells with angiotensin II enhances paracrine effects, angiogenesis, gap junction formation and therapeutic efficacy for myocardial infarction. Int. J. Cardiol. \n                           188, 22\u201332 (2015).","journal-title":"Int. J. Cardiol."},{"key":"10122_CR58","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","volume":"61","author":"J Bartunek","year":"2013","unstructured":"Bartunek, J. et al. Cardiopoietic stem cell therapy in heart failure: The C-CURE (cardiopoietic stem cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. J. Am. Coll. Cardiol. \n                           61, 2329\u20132338 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10122_CR59","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.ijcard.2005.05.072","volume":"109","author":"T Wang","year":"2006","unstructured":"Wang, T., Xu, Z., Jiang, W. & Ma, A. Cell-to-cell contact induces mesenchymal stem cell to differentiate into cardiomyocyte and smooth muscle cell. Int. J. Cardiol. \n                           109, 74\u201381 (2006).","journal-title":"Int. J. Cardiol."},{"key":"10122_CR60","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.yjmcc.2006.07.002","volume":"42","author":"X Li","year":"2007","unstructured":"Li, X. et al. Bone marrow mesenchymal stem cells differentiate into functional cardiac phenotypes by cardiac microenvironment. J. Mol. Cell. Cardiol. \n                           42, 295\u2013303 (2007).","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10122_CR61","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1016\/j.bbamem.2011.09.025","volume":"1818","author":"PR Brink","year":"2012","unstructured":"Brink, P. R., Valiunas, V., Gordon, C., Rosen, M. R. & Cohen, I. S. Can gap junctions deliver? Biochim. Biophys. Acta \n                           1818, 2076\u201381 (2012).","journal-title":"Biochim. Biophys. Acta"},{"key":"10122_CR62","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.jacc.2007.11.040","volume":"51","author":"J-Y Hahn","year":"2008","unstructured":"Hahn, J.-Y. et al. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction. J. Am. Coll. Cardiol. \n                           51, 933\u201343 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"10122_CR63","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.addr.2010.09.013","volume":"62","author":"T Meyerrose","year":"2010","unstructured":"Meyerrose, T. et al. Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors. Advanced Drug Delivery Reviews \n                           62, 1167\u20131174 (2010).","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10122_CR64","doi-asserted-by":"publisher","first-page":"346","DOI":"10.18632\/oncotarget.868","volume":"4","author":"H Lee","year":"2013","unstructured":"Lee, H., Finniss, S., Cazacu, S. & Bucris, E. Mesenchymal stem cells deliver synthetic microRNA mimics to glioma cells and glioma stem cells and inhibit their cell migration and self-renewal. Oncotarget \n                           4, 346\u2013361 (2013).","journal-title":"Oncotarget"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10122-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10122-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10122-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:42:52Z","timestamp":1671788572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10122-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10122"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10122-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]},"assertion":[{"value":"21 March 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9755"}}